Join us for the Mansfield Pitch Competition, an exciting day of life science innovation, networking and opportunity.
โฐ When: May 21, 2024, 9 AM - 3 PM.
๐ Where: Mansfield Bio-Incubator, 241 Francis Ave Mansfield, MA 02048
๐ Featured: 14 handpicked start-ups (see the list below) representing therapeutics (oncology, diabetes, Parkinson's), medical devices (women's health, smudge-proof glasses, opioid detection), diagnostics (cervical cancer) and biotechnology (bio tools, genetic diseases, tissue engineering).
In addition, there will be a graduation ceremony for the Spring 2024 Mentoring Program cohort consisting of three presenting startups (Neuronity Therapeutics, Emitech, and Unsmudgeable).
๐ฅ Attending: Investors, entrepreneurs, mentors, life science professionals, business development experts, sponsors
๐ Why attend:
ยง Learn about innovations that will revolutionize healthcare
ยง Explore investment opportunities
ยง Network with industry veterans and the new generation shaping the future of life sciences
ยง Showcase your products and services to a targeted audience of professionals and stakeholders
The Prizes Are:
$20,000 for first place;
$12,000 for second place;
$8,000 for third place.
We look forward to seeing you in Mansfield. Please feel free to share this information with your colleagues.
Agenda:
9:00 am - 10:00 am: Doors Open, Breakfast and Networking
10:00 am -10:05 am: Opening Remarks, Russ Yukhananov, President, Mansfield Bio-Incubator
10:05 am -10:10 am: Christopher McDermott, Director of Economic Development, Town of Mansfield
10:10 am -10:15 am: Rep. Jay Barrows (R), Massachusetts House of Representatives, 1st Bristol
10:15 am -10:20 am: Sarah Stanton, Undersecretary of Economic Strategies, Executive Office of Housing and Economic Development (EOHED), Commonwealth of Massachusetts
10:20 am -10:25 am: Introduction to the Pitch Competition, Alex Shlyankevich, Investor Relations Director, Mansfield Bio-Incubator
10:25 am -11:25 am: Company Presentations
11:25 am -11:40 am: Mentoring Program Graduation Ceremony (Spring 2024 Cohort)
11:40 am -12:30 pm: Lunch, Networking, Tour of Mansfield Bio-Incubator
12:30 pm - 1:40 pm: Company Presentations
1:40 pm - 2:10 pm: Judges' Deliberations, Networking
2:10 pm - 2:25 pm: Award Ceremony
2:25 pm - 2:30 pm: Concluding Remarks, Alexander Margulis, Chief Operating Officer, Mansfield Bio-Incubator
CONTESTANTS
Therapeutics
1. Neuronity Therapeutics โ Revolutionizing the treatment of neurological disorders by restoring a healthy immune system in the aging brain.
2. Opprtna Therapeutics โ Empowering health through precision aptamer therapeutics.
3. Manhattan BioSolutions โ Next-generation precision biologics that harness the power of host defense adaptations to transform cancer treatment paradigms.
4. Guardian Bio โ Next-generation dendritic cell therapy for solid tumors utilizing newly discovered cDC1 subtype with the first clinical trial planned in melanoma.
5. Palate Therapeutics โ Revolutionizing metabolic health by targeting taste buds.
6. Therabene โ First-in-class targeted therapies for the cure of hard-to-treat lung, pancreatic, and triple-negative breast cancer.
Diagnostics and Devices
7. 3Daughters โ Evolutionary healthcare for women with a novel targeted uterine delivery platform to address the neglected problem of IUD insertion pain.
8. Lilypad Health โ At-home non-invasive menstrual blood screening tool for gynecological diseases and biomarkers such as HPV, STDs, and fertility hormones.
9. Emitech โ Revolutionizing the drug testing industry with an exceptionally convenient, accurate, and cost-effective test.
10. Unsmudgeable โ A green permanent anti-smudge lens coating for a lifetime of clear vision that improves safety, productivity, and comfort.
Biotechnology Enablers
11. PurCell Bio โ Meticulously engineered, animal-free cell culture media systems to meet the evolving needs of advanced biotechnologies.
12. DINYA DNA โ Enabling innovation in the life sciences with the next generation of gene synthesis.
13. 100XBIO โ Automated platform for multiplex T-cell analysis.